Skip to NavigationSkip to content

News

0
NHS image
Internal report into failings ‘deliberately suppressed’, according to independent investigation
0
Lundbeck image
Lundbeck the hardest hit with €94m sanction in alleged generic blocking
0
GSK image
South African firm Aspen makes approach for portfolio and French manufacturing site
0
Lilly image
Firm exercises option on diabetes candidate TT-401 and will take it into Phase II